| Genomic Health Announces Six New Studies Including Four Oral Presentations Covering Breast, Colon and First Study in Renal Cancer Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire) Genomic Health, Inc. today announced that the company will present results from six separate studies at the American Society of Clinical Oncology Annual Meeting, taking place June 4-8, 2010 at McCormick Place in Chicago.  The studies include four oral presentations covering breast, colon and renal cancers.  The company markets the widely-adopted Oncotype DX® breast cancer test, which is clinically validated to predict chemotherapy benefit as well as the likelihood of recurrence in early-stage breast cancer patients.  In addition, the company launched the Oncotype DX colon cancer test in January 2010. us.rd.yahoo.com |
Quest Diagnostics Again Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' (PR Newswire) The National Business Group on Health has awarded its 2010 Best Employers for Healthy Lifestyles Platinum Award to Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services. us.rd.yahoo.com |
Reports Cite Risks of Blood-Clot Devices The FDA and the Archives of Internal Medicine warn of problems associated with some devices used to keep blood clots from traveling to the lungs. online.wsj.com |
Race On to Prevent Clots Studies of two experimental drugs provided fuel for a race to develop medicines to replace blood thinner warfarin, a global market that could eventually exceed $20 billion a year in revenue. online.wsj.com |
LSI Industries CEO Discusses F1Q2011 Results - Earnings Call Transcript LSI Industries, Inc. (LYTS)F1Q2011 (Qtr End 09/30/10) Earnings Conference CallOctober 21, 2010 3 PM ETComplete Story » seekingalpha.com |